Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15019)
All Articles published online
|
Publishing Process of This Article
|
May 7, 2015 (publication date) through Apr 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mo C, Sun G, Lu ML, Zhang L, Wang YZ, Sun X, Yang YS. Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries. World J Gastroenterol 2015; 21(17): 5382-5392 [PMID: 25954113 DOI: 10.3748/wjg.v21.i17.5382] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i17/5382.htm |
| Number | Citing Articles |
| 1 |
Alexandra Demcsák, Tamás Lantos, Emese Réka Bálint, Petra Hartmann, Áron Vincze, Judit Bajor, László Czopf, Hussain Alizadeh, Zoltán Gyöngyi, Katalin Márta, Alexandra Mikó, Zsolt Szakács, Dániel Pécsi, Péter Hegyi, Imre László Szabó. PPIs Are Not Responsible for Elevating Cardiovascular Risk in Patients on Clopidogrel—A Systematic Review and Meta-Analysis. Frontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.01550
|
| 2 |
Nina A. Hilkens, Ale Algra, Hans Christoph Diener, Philip M. Bath, László Csiba, Werner Hacke, L. Jaap Kappelle, Peter J. Koudstaal, Didier Leys, Jean-Louis Mas, Ralph L. Sacco, Jacoba P. Greving. Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke. Stroke 2021; 52(10): 3258 doi: 10.1161/STROKEAHA.120.031755
|
| 3 |
Wen Hu, Jin Tong, Xue Kuang, Weijie Chen, Zengzhang Liu. Influence of proton pump inhibitors on clinical outcomes in coronary heart disease patients receiving aspirin and clopidogrel. Medicine 2018; 97(3): e9638 doi: 10.1097/MD.0000000000009638
|
| 4 |
Ramesh GN, Richard Hunt, Leonid B Lazebnik, Yury C Marakhouski, Mircea Manuc, Khin S Aye, Dmitry S Bordin, Natalia V Bakulina, Baurzhan S Iskakov, Abror A Khamraev, Yurii M Stepanov, Reidwaan Ally, Amit Garg. International Consensus on Guiding Recommendations for Management of Patients with Nonsteroidal Antiinflammatory Drugs Induced Gastropathy-ICON-G. Euroasian Journal of Hepato-Gastroenterology 2018; 8(2): 148 doi: 10.5005/jp-journals-10018-1281
|
| 5 |
Lara Aguilera Castro, Carlos Martín de Argila de Prados, Agustín Albillos Martínez. Practical considerations in the management of proton-pump inhibitors. Revista Española de Enfermedades Digestivas 2015; doi: 10.17235/reed.2015.3812/2015
|
| 6 |
Azita H. Talasaz, Parham Sadeghipour, Luis Ortega-Paz, Hessam Kakavand, Maryam Aghakouchakzadeh, Craig Beavers, John Fanikos, John W. Eikelboom, Deborah M. Siegal, Manuel Monreal, David Jimenez, Muthiah Vaduganathan, Lana A. Castellucci, Adam Cuker, Geoffrey D. Barnes, Jean M. Connors, Eric A. Secemsky, Benjamin W. Van Tassell, Raffaele De Caterina, Jacob E. Kurlander, Ali Aminian, Gregory Piazza, Samuel Z. Goldhaber, Lisa Moores, Saskia Middeldorp, Ajay J. Kirtane, Mitchell S. V. Elkind, Dominick J. Angiolillo, Stavros Konstantinides, Gregory Y. H. Lip, Gregg W. Stone, Mary Cushman, Harlan M. Krumholz, Roxana Mehran, Deepak L. Bhatt, Behnood Bikdeli. Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease. Nature Reviews Cardiology 2024; doi: 10.1038/s41569-024-01003-3
|
| 7 |
Carmelo José Espinosa-Almanza, Hernando Gaitán-Duarte. Enfermedad renal crónica y sangrado entre pacientes bajo profilaxis con heparinas de bajo peso molecular. Revista de la Facultad de Medicina 2017; 65(4): 627 doi: 10.15446/revfacmed.v65n4.59769
|
| 8 |
Lorenzo Porta, Francesca Baorda, Alessandra Fusco. Is proton pump inhibitors’ prophylaxis indicated for patients on antiplatelet therapy?. Internal and Emergency Medicine 2018; 13(4): 585 doi: 10.1007/s11739-018-1827-9
|
| 9 |
Esra’a Samara, Zaher Nazzal, Shayma Naghnaghia, Rowa’ AL-Ramahi, Muhammad Eid Akkawi. Potentially inappropriate medication uses and associated factors among elderly primary health care clinics attendees: A call to action. PLOS ONE 2023; 18(8): e0290625 doi: 10.1371/journal.pone.0290625
|
| 10 |
Tatyana A. Shamliyan, Maria Middleton, Clarissa Borst. Patient-centered Outcomes with Concomitant Use of Proton Pump Inhibitors and Other Drugs. Clinical Therapeutics 2017; 39(2): 404 doi: 10.1016/j.clinthera.2017.01.011
|
| 11 |
Javad Parvizi, Ronald Huang, Camilo Restrepo, Antonia F. Chen, Matthew S. Austin, William J. Hozack, Jess H. Lonner. Low-Dose Aspirin Is Effective Chemoprophylaxis Against Clinically Important Venous Thromboembolism Following Total Joint Arthroplasty. Journal of Bone and Joint Surgery 2017; 99(2): 91 doi: 10.2106/JBJS.16.00147
|
| 12 |
Aktualisierte S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Juli 2022 – AWMF-Registernummer: 021–001. Zeitschrift für Gastroenterologie 2023; 61(05): 544 doi: 10.1055/a-1975-0414
|
| 13 |
Masaomi Tatsuzawa, Ryuichi Ogawa, Atsushi Ohkubo, Kazuyo Shimojima, Kunimi Maeda, Hirotoshi Echizen, Akihisa Miyazaki. Influence of proton pump inhibitors and histamine H2 receptor antagonists on serum phosphorus level control by calcium carbonate in patients undergoing hemodialysis: a retrospective medical chart review. Journal of Pharmaceutical Health Care and Sciences 2016; 2(1) doi: 10.1186/s40780-016-0068-1
|
| 14 |
Carl J. Lavie, Colin W. Howden, James Scheiman, James Tursi. Upper Gastrointestinal Toxicity Associated With Long-Term Aspirin Therapy: Consequences and Prevention. Current Problems in Cardiology 2017; 42(5): 146 doi: 10.1016/j.cpcardiol.2017.01.006
|
| 15 |
Zhuoya Li, Zheng Wang, Baile Shen, Chen Chen, Xiaoyun Ding, Haojun Song. Effects of aspirin on the gastrointestinal tract: Pros vs. cons (Review). Oncology Letters 2020; 20(3): 2567 doi: 10.3892/ol.2020.11817
|
| 16 |
O. M. Drapkina, T. V. Vavilova, Yu. A. Karpov, Zh. D. Kobalava, N. V. Lomakin, А. I. Martynov, E. V. Roitman, D. A. Sychev. The resolution of the Expert Council on current issues of the use of acetylsalicylic acid for the purpose of primary prevention of cardiovascular diseases in the light of new scientific data and updated clinical guidelines. Cardiovascular Therapy and Prevention 2023; 21(12): 3487 doi: 10.15829/1728-8800-2022-3487
|
| 17 |
James R. Lawrence, Gwendoline J. Baxter, John R. Paterson. Aspirin for cancer is no mere antiplatelet prototype. There is potential in its ancient roots. Medical Hypotheses 2016; 94: 74 doi: 10.1016/j.mehy.2016.07.001
|
| 18 |
Luis A. García Rodríguez, Angel Lanas, Montse Soriano-Gabarró, Pareen Vora, Lucía Cea Soriano. Effect of Proton Pump Inhibitors on Risks of Upper and Lower Gastrointestinal Bleeding among Users of Low-Dose Aspirin: A Population-Based Observational Study. Journal of Clinical Medicine 2020; 9(4): 928 doi: 10.3390/jcm9040928
|
| 19 |
Bianca Clerici, Marco Cattaneo. Pharmacological Efficacy and Gastrointestinal Safety of Different Aspirin Formulations for Cardiovascular Prevention: A Narrative Review. Journal of Cardiovascular Development and Disease 2023; 10(4): 137 doi: 10.3390/jcdd10040137
|
| 20 |
Anca Negovan, Mihaela Iancu, Valeriu Moldovan, Kinga Sàrkàny, Simona Bataga, Simona Mocan, Ioan Țilea, Claudia Banescu. The contribution of clinical and pathological predisposing factors to severe gastro-duodenal lesions in patients with long-term low-dose aspirin and proton pump inhibitor therapy. European Journal of Internal Medicine 2017; 44: 62 doi: 10.1016/j.ejim.2017.05.017
|
| 21 |
Yao-Sheng Shang, Peng-Yu Zhong, Ying Ma, Nan Bai, Ying Niu, Zhi-Lu Wang. Efficacy and Safety of Proton Pump Inhibitors in Patients With Coronary Artery Diseases Receiving Oral Antiplatelet Agents and/or Anticoagulants: A Systematic Review and Meta-Analysis. Journal of Cardiovascular Pharmacology 2022; 80(1): 1 doi: 10.1097/FJC.0000000000001284
|
| 22 |
Michael E. Farkouh. A COGENT Argument for Gastrointestinal Protection With Low-Dose Aspirin ∗. Journal of the American College of Cardiology 2016; 67(14): 1672 doi: 10.1016/j.jacc.2016.01.039
|
| 23 |
Dorota Ksiądzyna, Adam Szeląg. The Proton Pump Inhibitors Use and COVID-19 from Prior to Vaccination Perspective: A Review. Digestive Diseases 2023; 41(3): 513 doi: 10.1159/000527501
|
| 24 |
C. Suárez Ferrer, J.L. Rueda García, M.D. Martín-Arranz. Gastritis y gastropatías (I). Gastritis infecciosas y tóxicas. Medicine - Programa de Formación Médica Continuada Acreditado 2024; 14(2): 76 doi: 10.1016/j.med.2024.02.002
|
| 25 |
Mariko Hojo, Takashi Asahara, Akihito Nagahara, Tsutomu Takeda, Kohei Matsumoto, Hiroya Ueyama, Kenshi Matsumoto, Daisuke Asaoka, Takuya Takahashi, Koji Nomoto, Yuichiro Yamashiro, Sumio Watanabe. Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors. Digestive Diseases and Sciences 2018; 63(11): 2940 doi: 10.1007/s10620-018-5122-4
|
| 26 |
Ramon Luengo-Fernandez, Linxin Li, Peter M Rothwell. Costs of bleeding on long-term antiplatelet treatment without routine co-prescription of proton-pump inhibitors. International Journal of Stroke 2021; 16(6): 719 doi: 10.1177/1747493019879658
|
| 27 |
Hui Hua, Hongying Zhang, Qingbin Kong, Jiao Wang, Yangfu Jiang. Complex roles of the old drug aspirin in cancer chemoprevention and therapy. Medicinal Research Reviews 2019; 39(1): 114 doi: 10.1002/med.21514
|
| 28 |
Joachim Mössner. The Indications, Applications, and Risks of Proton Pump Inhibitors. Deutsches Ärzteblatt international 2016; doi: 10.3238/arztebl.2016.0477
|
| 29 |
Alexandru Burlacu, Simonetta Genovesi, David Goldsmith, Patrick Rossignol, Alberto Ortiz, Philip A. Kalra, Jolanta Małyszko, Maciej Banach, Mehmet Kanbay, Adrian Covic. Bleeding in advanced CKD patients on antithrombotic medication – A critical appraisal. Pharmacological Research 2018; 129: 535 doi: 10.1016/j.phrs.2017.12.004
|
| 30 |
Marouf Mouhammad Alhalabi. Mortality and risk factors associated with peptic ulcer bleeding among adult inpatients of Damascus Hospital, Syria: A cross-sectional study. Medicine 2023; 102(17): e33699 doi: 10.1097/MD.0000000000033699
|
| 31 |
Anna Graipe, Anders Ulvenstam, Anna-Lotta Irevall, Lars Söderström, Thomas Mooe. Incidence and predictors of serious bleeding during long-term follow-up after acute coronary syndrome in a population-based cohort study. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-01525-7
|
| 32 |
Peter C. Elwood, Janet E. Pickering, Gareth Morgan, Julieta Galante, Alison L. Weightman, Delyth Morris, Marcus Longley, Malcolm Mason, Richard Adams, Sunil Dolwani, John Chia W. K., Angel Lanas, Daotai Nie. Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients?. PLOS ONE 2018; 13(9): e0203957 doi: 10.1371/journal.pone.0203957
|
| 33 |
Isabel Laucirica, Pilar García Iglesias, Xavier Calvet. Úlcera péptica. Medicina Clínica 2023; 161(6): 260 doi: 10.1016/j.medcli.2023.05.008
|
| 34 |
Jemi Feiona Vergil Andrews, Divya Bharathi Selvaraj, Akshay Kumar, Syed Aasish Roshan, Muthuswamy Anusuyadevi, Mahesh Kandasamy. A Mild Dose of Aspirin Promotes Hippocampal Neurogenesis and Working Memory in Experimental Ageing Mice. Brain Sciences 2023; 13(7): 1108 doi: 10.3390/brainsci13071108
|
| 35 |
C. Schulz, S. Nitschmann. Helicobacter-pylori-Eradikation zur Prävention von Ulkusblutungen. Die Innere Medizin 2023; 64(5): 506 doi: 10.1007/s00108-023-01493-2
|
| 36 |
Weijun Guo, Wenlin Lu, Yujun Xu, Liansheng Wang, Qin Wei, Qingyun Zhao. Relationship between Adverse Gastric Reactions and the Timing of Enteric-Coated Aspirin Administration. Clinical Drug Investigation 2017; 37(2): 187 doi: 10.1007/s40261-016-0474-z
|
| 37 |
Nina A. Hilkens, Linxin Li, Peter M. Rothwell, Ale Algra, Jacoba P. Greving. External Validation of Risk Scores for Major Bleeding in a Population-Based Cohort of Transient Ischemic Attack and Ischemic Stroke Patients. Stroke 2018; 49(3): 601 doi: 10.1161/STROKEAHA.117.019259
|
| 38 |
Susanna M. Wallerstedt, Johan Fastbom, Johannes Linke, Sigurd Vitols. Long‐term use of proton pump inhibitors and prevalence of disease‐ and drug‐related reasons for gastroprotection—a cross‐sectional population‐based study. Pharmacoepidemiology and Drug Safety 2017; 26(1): 9 doi: 10.1002/pds.4135
|
| 39 |
Jing Zhao, Yihong Fan, Wu Ye, Wen Feng, Yue Hu, Lijun Cai, Bin Lu. The Protective Effect of Teprenone on Aspirin-Related Gastric Mucosal Injuries. Gastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/6532876
|
| 40 |
Aitor Lanas-Gimeno, Gonzalo Hijos, Ángel Lanas. Proton pump inhibitors, adverse events and increased risk of mortality. Expert Opinion on Drug Safety 2019; 18(11): 1043 doi: 10.1080/14740338.2019.1664470
|
| 41 |
Cody Magnusson. Antiplatelet cessation to manage bleeding events in elderly people. The Lancet 2017; 390(10112): 2547 doi: 10.1016/S0140-6736(17)33086-6
|
| 42 |
Norihito Kanai, Masazumi Ando, Momoko Shimodate, Yoshiko Miyazaki, Toshio Saito. Influence of Hospital Formularies on Outpatient Prescribing Practices: Analysis of the Introduction of a Local Formulary: A Single-Center, 2-Year Follow-Up, Retrospective Cohort Study of a Local Formulary in Japan. INQUIRY: The Journal of Health Care Organization, Provision, and Financing 2022; 59: 004695802210878 doi: 10.1177/00469580221087876
|
| 43 |
Jaqui Walker. Low-dose aspirin for the prevention of atherothrombosis across the cardiovascular risk continuum. Cardiology Plus 2022; 7(2): 64 doi: 10.1097/CP9.0000000000000017
|
| 44 |
Maurizio Giuseppe Abrignani, Alberto Lombardo, Annabella Braschi, Nicolò Renda, Vincenzo Abrignani. Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of view. World Journal of Cardiology 2023; 15(8): 375-394 doi: 10.4330/wjc.v15.i8.375
Abstract(403) |
Core Tip(239) |
Full Article(HTML)(4975)
|
Full Article with Cover (PDF)-1012K(118)
|
Full Article (Word)-171K(24)
|
Audio-1310K(4)
|
Peer-Review Report-333K(28)
|
Answering Reviewers-122K(30)
|
Full Article (PDF)-561K(704)
|
Full Article (XML)-403K(32)
|
Times Cited (1)
|
Total Visits (7675)
|
Open
|
| 45 |
Linxin Li, Olivia C Geraghty, Ziyah Mehta, Peter M Rothwell. Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study. The Lancet 2017; 390(10093): 490 doi: 10.1016/S0140-6736(17)30770-5
|
| 46 |
Xiao-Ying Li, Li Li, Sang-Hoon Na, Francesca Santilli, Zhongwei Shi, Michael Blaha. Implications of the heterogeneity between guideline recommendations for the use of low dose aspirin in primary prevention of cardiovascular disease. American Journal of Preventive Cardiology 2022; 11: 100363 doi: 10.1016/j.ajpc.2022.100363
|
| 47 |
Masato Nakamura, Tomoko Iizuka, Kei Sagawa, Kenji Abe, Shuichi Chikada, Miyuki Arai. Prasugrel for Japanese patients with acute coronary syndrome in short-term clinical practice (PRASFIT-Practice I): a postmarketing observational study. Cardiovascular Intervention and Therapeutics 2018; 33(2): 135 doi: 10.1007/s12928-017-0459-8
|
| 48 |
N. S. Lapina, A. A. Alekseeva, A. D. Vershinina, N. S. Khruleva, D. S. Zlobina, L. Yu. Koroleva. Gastrointestinal Bleeding in Patients with Coronary Heart Disease: Preventive Options. Kardiologiia 2020; 60(7): 125 doi: 10.18087/cardio.2020.7.n942
|
| 49 |
R. H. Olie, P. E. J. van der Meijden, H. M. H. Spronk, H. ten Cate. . Handbook of Experimental Pharmacology 2020; doi: 10.1007/164_2020_357
|
| 50 |
Kelly E. Lloyd, Robbie Foy, Louise H. Hall, Lucy Ziegler, Sophie M. C. Green, Zainab F. Haider, David G. Taylor, Mairead MacKenzie, Samuel G. Smith. Barriers and facilitators to using aspirin for preventive therapy: a qualitative study exploring the views and experiences of people with Lynch syndrome and healthcare providers. Hereditary Cancer in Clinical Practice 2022; 20(1) doi: 10.1186/s13053-022-00235-z
|
| 51 |
|
| 52 |
Carmelo J. Espinosa Almanza, Hernando G. Gaitan Duarte, Oscar A. Guevara Cruz, Luis F. Sanchez Solanilla, Rocio P. Sanabria Rodriguez. Association between renal dysfunction and the development of bleeding during prophylactic doses of low molecular weight heparins, a nested case-control study. Gazzetta Medica Italiana Archivio per le Scienze Mediche 2019; 178(1-2) doi: 10.23736/S0393-3660.17.03704-4
|
| 53 |
Sajesh K. Veettil, Saranrat Sadoyu, Elizabeth M Bald, Viji P. Chandran, Scott Anh Tuan Khuu, Panitan Pitak, Yeong Yeh Lee, Athira Balakrishnan Nair, Paul T. Antony, Alexander C. Ford, Nathorn Chaiyakunapruk. Association of proton‐pump inhibitor use with adverse health outcomes: A systematic umbrella review of meta‐analyses of cohort studies and randomised controlled trials. British Journal of Clinical Pharmacology 2022; 88(4): 1551 doi: 10.1111/bcp.15103
|
| 54 |
Hyun Kuk Kim, Youngkeun Ahn, Kiyuk Chang, Young-Hoon Jeong, Joo-Yong Hahn, Eun Ho Choo, Min Chul Kim, Hyo-Soo Kim, Weon Kim, Myeong-Chan Cho, Yangsoo Jang, Chong Jin Kim, Myung Ho Jeong, Shung Chull Chae. 2020 Korean Society of Myocardial Infarction Expert Consensus Document on Pharmacotherapy for Acute Myocardial Infarction. Korean Circulation Journal 2020; 50(10): 845 doi: 10.4070/kcj.2020.0196
|
| 55 |
Lei Fang, Wansi Zhong, Xiaoxian Gong, Zhicai Chen, Yi Chen, Shenqiang Yan, Min Lou. Association of Proton Pump Inhibitor Prophylaxis on Clinical Outcome in Acute Ischemic Stroke in China: A Multicenter Retrospective Cohort Study. Journal of Clinical Medicine 2022; 11(23): 6881 doi: 10.3390/jcm11236881
|
| 56 |
Isabel Laucirica, Pilar Garcia Iglesias, Xavier Calvet. Peptic ulcer. Medicina Clínica (English Edition) 2023; 161(6): 260 doi: 10.1016/j.medcle.2023.05.015
|
| 57 |
Antonio Rodríguez‐Miguel, Luis A. García‐Rodríguez, Miguel Gil, Diana Barreira‐Hernández, Sara Rodríguez‐Martín, Francisco J. de Abajo. Population‐based case‐control study: chemoprotection of colorectal cancer with non‐aspirin nonsteroidal anti‐inflammatory drugs and other drugs for pain control. Alimentary Pharmacology & Therapeutics 2019; 50(3): 295 doi: 10.1111/apt.15333
|
| 58 |
Supinya Dechanont, Arom Jedsadayanmata, Bodin Butthum, Chuenjid Kongkaew. Hospital Admissions Associated With Medication-Related Problems in Thai Older Patients: A Multicenter Prospective Observational Study. Journal of Patient Safety 2021; 17(1): 15 doi: 10.1097/PTS.0000000000000627
|
| 59 |
Hiroyuki Tsujimoto, Yuki Hirata, Yasuhiro Ueda, Naohiko Kinoshita, Hideki Tawa, Yasuyoshi Tanaka, Ryoji Koshiba, Kazuhiro Ota, Yuichi Kojima, Kazuki Kakimoto, Toshihisa Takeuchi, Takako Miyazaki, Shiro Nakamura, Kazuhide Higuchi. Effect of a proton-pump inhibitor on intestinal microbiota in patients taking low-dose aspirin. European Journal of Clinical Pharmacology 2021; 77(11): 1639 doi: 10.1007/s00228-021-03167-0
|
| 60 |
Makiko Iwasawa, Kyoichi Wada, Mitsutaka Takada. Gastrointestinal risk factors and prescribing pattern of antiulcer agents in patients taking low-dose aspirin in Japan. International Journal of Pharmacy Practice 2018; 26(4): 369 doi: 10.1111/ijpp.12412
|
| 61 |
Alan P Jacobsen, John W McEvoy. Changing place for aspirin in primary prevention of cardiovascular disease. Drug and Therapeutics Bulletin 2020; 58(1): 3 doi: 10.1136/dtb.2019.000043
|
| 62 |
Wolfgang Fischbach, Jan Bornschein, Jörg C. Hoffmann, Sibylle Koletzko, Alexander Link, Lukas Macke, Peter Malfertheiner, Kerstin Schütte, Dieter-Michael Selgrad, Sebastian Suerbaum, Christian Schulz. Update S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS). Zeitschrift für Gastroenterologie 2024; 62(02): 261 doi: 10.1055/a-2181-2225
|
| 63 |
|
| 64 |
Guillermo García-Rayado, Carlos Sostres, Angel Lanas. Aspirin and omeprazole for secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers. Expert Review of Clinical Pharmacology 2017; 10(8): 875 doi: 10.1080/17512433.2017.1324782
|
| 65 |
Moritz Schmidbauer, Johannes Wischmann, Konstantinos Dimitriadis, Lars Kellert. Sekundärprophylaxe des ischämischen Schlaganfalls. Die Innere Medizin 2023; 64(12): 1171 doi: 10.1007/s00108-023-01615-w
|
| 66 |
Sven Lerch. Akuttherapie des ischämischen Schlaganfalls. Geriatrie-Report 2020; 15(1): 40 doi: 10.1007/s42090-019-0003-3
|
| 67 |
Tomoari Kamada, Kiichi Satoh, Toshiyuki Itoh, Masanori Ito, Junichi Iwamoto, Tadayoshi Okimoto, Takeshi Kanno, Mitsushige Sugimoto, Toshimi Chiba, Sachiyo Nomura, Mitsuyo Mieda, Hideyuki Hiraishi, Junji Yoshino, Atsushi Takagi, Sumio Watanabe, Kazuhiko Koike. Evidence-based clinical practice guidelines for peptic ulcer disease 2020. Journal of Gastroenterology 2021; 56(4): 303 doi: 10.1007/s00535-021-01769-0
|
| 68 |
Luis A. García Rodríguez, Mar Martín-Pérez, Charles H. Hennekens, Peter M. Rothwell, Angel Lanas, Tobias Eckle. Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies. PLOS ONE 2016; 11(8): e0160046 doi: 10.1371/journal.pone.0160046
|
| 69 |
Jennifer S. Davis, Preeti Kanikarla-Marie, Mihai Gagea, Patrick L. Yu, Dexing Fang, Manu Sebastian, Peiying Yang, Ernest Hawk, Roderick Dashwood, Lenard M. Lichtenberger, David Menter, Scott Kopetz. Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07311-4
|